The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...

Recent clinical trial results in pancreatic and rectal cancers are challenging long-standing treatment norms, showing unprecedented survival gains and organ preservation potential. Innovations include ...

Trial Designed to Demonstrate Target Engagement, Safety, and Pharmacokinetics CLEVELAND, April 7, 2026 /PRNewswire/ -- NeuroTherapia, Inc., a clinical-stage company focused on developing oral ...

These courts in L.A. and elsewhere operate on models built around male patterns of addiction and accountability. Hawaii tried ...

Treatment with the investigational next-generation KRAS-G12C inhibitor elisrasib led to clinical benefit in patients with ...

Recent studies have suggested that sugar substitutes might not be the free lunch they're advertised as. We asked experts what ...

Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced ...

Seasoned Biopharma leader bringing deep commercial experience to shape and inform corporate strategy, clinical trial design ...

Boston Scientific (NYSE:BSX) today shared new clinical findings supporting its wide-ranging electrophysiology (EP) portfolio.

After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to ...

Chimeric antigen receptor T-cell therapy conferred sustained benefit to individuals with high-risk smoldering multiple myeloma, according to phase 2 trial results. All patients who received a single ...